Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug.
Emtora Biosciences has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Emtora Biosciences's investors include Cancer Prevention and Research Institute of Texas, UT Horizon Fund.
Emtora Biosciences is headquartered in San Antonio, United States.
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug.
Emtora Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emtora Biosciences — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/emtora-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Emtora Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/emtora-biosciences
{{cite web |title=Emtora Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/emtora-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated